NCT00722566 · BASELINE

Baseline characteristics

A Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple Myeloma · Source last updated 2011-10-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

counts
group Id
BG000
value
148
group Id
BG001
value
74
group Id
BG002
value
222
units
Participants

groups

description
VELCADE 1.3 mg/m\^2 administered by subcutaneous injection on Days 1, 4, 8, and 11 of a 3-week cycle for 8 cycles.
id
BG000
title
VELCADE Subcutaneous
description
VELCADE 1.3 mg/m\^2 administered by intravenous infusion on Days 1, 4, 8, and 11 of a 3-week cycle for 8 cycles.
id
BG001
title
VELCADE Intravenous
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
<=18 years
measurements
group Id
BG000
value
74
group Id
BG001
value
37
group Id
BG002
value
111
title
Between 18 and 65 years
measurements
group Id
BG000
value
74
group Id
BG001
value
37
group Id
BG002
value
111
title
>=65 years
param Type
COUNT_OF_PARTICIPANTS
title
Age, Categorical
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
spread
8.96
value
64.3
group Id
BG001
spread
12.11
value
64.0
group Id
BG002
spread
10.09
value
64.2
dispersion Type
STANDARD_DEVIATION
param Type
MEAN
title
Age Continuous
unit Of Measure
years
classes
categories
measurements
group Id
BG000
value
74
group Id
BG001
value
27
group Id
BG002
value
101
title
Female
measurements
group Id
BG000
value
74
group Id
BG001
value
47
group Id
BG002
value
121
title
Male
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
22
group Id
BG001
value
14
group Id
BG002
value
36
title
France
categories
measurements
group Id
BG000
value
7
group Id
BG001
value
5
group Id
BG002
value
12
title
Belgium
categories
measurements
group Id
BG000
value
2
group Id
BG001
value
4
group Id
BG002
value
6
title
Germany
categories
measurements
group Id
BG000
value
6
group Id
BG001
value
4
group Id
BG002
value
10
title
Netherlands
categories
measurements
group Id
BG000
value
6
group Id
BG001
value
3
group Id
BG002
value
9
title
United Kingdom
categories
measurements
group Id
BG000
value
51
group Id
BG001
value
17
group Id
BG002
value
68
title
Ukraine
categories
measurements
group Id
BG000
value
26
group Id
BG001
value
9
group Id
BG002
value
35
title
Russian Federation
categories
measurements
group Id
BG000
value
20
group Id
BG001
value
7
group Id
BG002
value
27
title
Poland
categories
measurements
group Id
BG000
value
5
group Id
BG001
value
8
group Id
BG002
value
13
title
Argentina
categories
measurements
group Id
BG000
value
3
group Id
BG001
value
3
group Id
BG002
value
6
title
India
param Type
NUMBER
title
Region of Enrollment
unit Of Measure
participants

Complete source fields

denoms

counts
group Id
BG000
value
148
group Id
BG001
value
74
group Id
BG002
value
222
units
Participants

groups

description
VELCADE 1.3 mg/m\^2 administered by subcutaneous injection on Days 1, 4, 8, and 11 of a 3-week cycle for 8 cycles.
id
BG000
title
VELCADE Subcutaneous
description
VELCADE 1.3 mg/m\^2 administered by intravenous infusion on Days 1, 4, 8, and 11 of a 3-week cycle for 8 cycles.
id
BG001
title
VELCADE Intravenous
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
<=18 years
measurements
group Id
BG000
value
74
group Id
BG001
value
37
group Id
BG002
value
111
title
Between 18 and 65 years
measurements
group Id
BG000
value
74
group Id
BG001
value
37
group Id
BG002
value
111
title
>=65 years
param Type
COUNT_OF_PARTICIPANTS
title
Age, Categorical
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
spread
8.96
value
64.3
group Id
BG001
spread
12.11
value
64.0
group Id
BG002
spread
10.09
value
64.2
dispersion Type
STANDARD_DEVIATION
param Type
MEAN
title
Age Continuous
unit Of Measure
years
classes
categories
measurements
group Id
BG000
value
74
group Id
BG001
value
27
group Id
BG002
value
101
title
Female
measurements
group Id
BG000
value
74
group Id
BG001
value
47
group Id
BG002
value
121
title
Male
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
22
group Id
BG001
value
14
group Id
BG002
value
36
title
France
categories
measurements
group Id
BG000
value
7
group Id
BG001
value
5
group Id
BG002
value
12
title
Belgium
categories
measurements
group Id
BG000
value
2
group Id
BG001
value
4
group Id
BG002
value
6
title
Germany
categories
measurements
group Id
BG000
value
6
group Id
BG001
value
4
group Id
BG002
value
10
title
Netherlands
categories
measurements
group Id
BG000
value
6
group Id
BG001
value
3
group Id
BG002
value
9
title
United Kingdom
categories
measurements
group Id
BG000
value
51
group Id
BG001
value
17
group Id
BG002
value
68
title
Ukraine
categories
measurements
group Id
BG000
value
26
group Id
BG001
value
9
group Id
BG002
value
35
title
Russian Federation
categories
measurements
group Id
BG000
value
20
group Id
BG001
value
7
group Id
BG002
value
27
title
Poland
categories
measurements
group Id
BG000
value
5
group Id
BG001
value
8
group Id
BG002
value
13
title
Argentina
categories
measurements
group Id
BG000
value
3
group Id
BG001
value
3
group Id
BG002
value
6
title
India
param Type
NUMBER
title
Region of Enrollment
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice